Friday, 4 April 2025
27.9 C
Singapore
29.8 C
Thailand
24.9 C
Indonesia
27.3 C
Philippines

Bioptimus embarks on a revolutionary AI journey in biology with US$35 million funding

Bioptimus, a Paris-based AI startup with a US$35 million seed round, is trailblazing in biology, aiming to transform healthcare with AI.

You are entering a realm where biology and artificial intelligence converge, brought to life by Bioptimus, an emerging generative AI startup based in Paris. This venture stands out with its razor-sharp focus on biology, applying the latest AI advancements exclusively to this vital scientific arena. Bioptimus isn’t just another AI company; it’s a pioneer, charting a course in unexplored territories of biological research.

Tackling the challenge of sensitive data

Imagine the complexities of training AI models in a domain where every piece of data is not just complex but shrouded in layers of confidentiality. This is the challenge Bioptimus embraces head-on. Diverging from the path of companies like OpenAI, which are gravitating towards content licensing, Bioptimus is navigating the intricate landscape of clinical data, a domain typically hidden from public scrutiny. This unique challenge underscores the groundbreaking nature of their work.

Furthermore, Bioptimus faces the high costs associated with AI development. Training sophisticated AI models demands state-of-the-art GPUs and a team of highly skilled researchers. Bioptimus has successfully raised an impressive US$35 million in seed funding to meet these demands. Sofinnova Partners spearhead this round and includes investments from an array of notable entities such as Bpifrance’s Large Venture fund, Frst, Cathay Innovation, Headline, Hummingbird, NJF Capital, Owkin, Top Harvest Capital, and Xavier Niel.

Visionary leadership and collaborative synergy

Guiding Bioptimus is Jean-Philippe Vert, who takes on the roles of co-founder and executive chairman while concurrently serving as the Chief R&D Officer at Owkin, a French biotech unicorn. The team’s technological expertise is bolstered by Rodolphe Jenatton, the CTO, who brings valuable experience from his tenure as a senior research scientist at Google. Complementing this leadership are several ex-researchers from Google DeepMind.

Bioptimus’s approach is further enhanced through a strategic partnership with Owkin. Utilising Owkin’s extensive multimodal patient data, collected through collaborations with top academic hospitals worldwide, Bioptimus has access to a diverse and rich dataset for training its foundational model. This synergy marks a unique collaboration, leveraging existing resources for groundbreaking research.

A strategic spin-off with a focused mission

Bioptimus can be viewed as a strategic offshoot of Owkin, conceived as a moonshot project. The daunting task of creating new AI models in biology necessitated the formation of a distinct entity, allowing for a more concentrated and practical approach. Vert explains that while building foundational biology models is not on Owkin’s immediate agenda, the partnership with Bioptimus aligns with their long-term vision, providing the necessary resources and specialisation for this ambitious undertaking.

A partnership with Amazon Web Services signifies Bioptimus’s commitment to utilising top-tier resources for its model training, leveraging Amazon’s advanced data centres. The implications of Bioptimus’s work are far-reaching. The AI models they develop are poised to transform disease diagnosis and precision medicine and lead to the discovery of new biomolecules for both medical and environmental applications.

In summary, Bioptimus represents a bold step into the future of biotechnology. It’s not just about launching a new company; it’s about reshaping the landscape of healthcare and environmental science through the innovative application of AI in biology.

Hot this week

Huawei reports 38% revenue surge as smartphone sales soar

Despite US sanctions, Huaweiโ€™s consumer business revenue surged 38% in 2024, driven by strong smartphone sales and home-grown chip production.

Synagie and HKT launch ShopHK to help Hong Kong brands expand into Southeast Asia

Synagie and HKT launch ShopHK, helping Hong Kong SMEs tap into Southeast Asia's booming US$600 billion e-commerce market.

Intel remains on course for next-gen CPUs

Intel CEO Lip-Bu Tan confirms that next-gen CPUs, including Panther Lake and Nova Lake, remain on track, with Panther Lake arriving in 2025.

Chinese EV makers urged to expand globally despite tariff challenges

Chinese EV makers are urged to expand globally despite rising tariffs. Industry experts stress the need for overseas production and strategic partnerships.

This tiny and affordable device upgrades any speaker with Wi-Fi streaming and hi-res audio

The Atonemo Streamplayer is a tiny, affordable device that adds Wi-Fi streaming and hi-res audio support to any speaker with a 3.5mm aux port.

Spotify introduces AI-powered ads and programmatic ad buying

Spotify unveils AI-powered ads and the Spotify Ad Exchange, making it easier for advertisers to reach Gen Z listeners with real-time bidding.

YouTube expands shopping affiliate programme in Singapore through Shopee partnership

YouTube teams up with Shopee to launch its Shopping affiliate programme in Singapore, giving creators new ways to monetise their content.

Misconceptions about STEM careers continue to deter young women in Singapore

New research shows stereotypes and lack of support are deterring young women from STEM careers, posing a risk to Singaporeโ€™s innovation goals.

Synagie and HKT launch ShopHK to help Hong Kong brands expand into Southeast Asia

Synagie and HKT launch ShopHK, helping Hong Kong SMEs tap into Southeast Asia's booming US$600 billion e-commerce market.

Related Articles